Mallinckrodt Pharmaceuticals is a global specialty biopharmaceutical and medical imaging company. The company’s Autoimmune and Rare Diseases business includes H.P. Acthar® Gel (repository corticotropin injection), indicated for use in multiple specialties including neurology, rheumatology, nephrology and pulmonology. Mallinckrodt’s other areas of focus include analgesics and central nervous system drugs for prescribing by office- and hospital-based physicians. To learn more about Mallinckrodt and Acthar, visit Exhibit #1612 or www.mallinckrodt.com.